Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Sohail R. Rana, MD
Healthcare Provider Director of Community Outreach and Education
Center for Sickle Cell Disease
2041 Georgia Ave NW
Washington, DC, United States
Dr. Rana is Professor of Pediatrics at Howard University and Director of Pediatric Hematology with primary focus on sickle cell disease. He has been providing care in a “medical home setting” to individuals with sickle cell disease for more than 30 years with an aim to provide all primary and specialty services at one site. He has conducted and participated in numerous studies related to sickle cell disease and advocated for individuals with sickle cell disease. He has organized seminars related to pain and stigma in sickle cell disease and produced many videos related to pain. He has been listed among the best doctors in America numerous times and he is a recipient of several awards from the sickle cell community and other institutions.
Representative Video:
Fighting the Stigma: Pain in Sickle Cell Disease – Elise 3
Representative Publications:
Pharmacogenetics of morphine: potential implications in sickle cell disease
Hydroxyurea and growth in young children with sickle cell disease
Differences in the clinical and genotypic presentation of sickle cell disease around the world
Related Content
-
George Atweh, MDGeorge Atweh, MD, is a professor and div...
-
Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice GuidelineBackground: Home oxygen therapy is ofte...
-
Sickle Cell Disease Program at Children’s HealthThe Sickle Cell Disease Program at Child...
-
University of Pittsburgh Medical Center, Heart and Vascular InstituteThe Vascular Medicine Institute at the U...
-
Social-Environmental Factors and Cognitive and Behavioral Functioning in Pediatric Sickle Cell DiseaseSickle cell disease (SCD), an inherited ...
-
Sickle Cell Disease Association of North TexasSCDA Tarrant is committed to providing m...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...